IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?
International Journal of Interferon, Cytokine and Mediator Research · 2011
DOI: 10.2147/ijicmr.s16320 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Interferon, Cytokine and Mediator Research, 2011. Verfasst von Babbette Lamarca und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Mississippi Medical Center, Jackson, MS, USA. Die Arbeit wurde bisher 50-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NHLBI NIH HHS, NICHD NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University of Mississippi Medical Center, Jackson, MS, USA.
Förderung
- NHLBI NIH HHS
- NICHD NIH HHS
Zitieren
APA
Lamarca, B., Brewer, J., & Wallace, K. (2011). IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?. International Journal of Interferon, Cytokine and Mediator Research. https://doi.org/10.2147/ijicmr.s16320
Vancouver
Lamarca B, Brewer J, Wallace K. IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?. International Journal of Interferon, Cytokine and Mediator Research. 2011. doi:10.2147/ijicmr.s16320
BibTeX
@article{Lamarca2011,
author = {Lamarca, Babbette and Brewer, Justin and Wallace, Kedra},
title = {IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?},
journal = {International Journal of Interferon, Cytokine and Mediator Research},
year = {2011},
doi = {10.2147/ijicmr.s16320}
}
EUVIMED